| 000 | 01721 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517160224.0 | ||
| 264 | 0 | _c20180605 | |
| 008 | 201806s 0 0 eng d | ||
| 022 | _a1600-0641 | ||
| 024 | 7 |
_a10.1016/j.jhep.2017.05.022 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMa, Peng-Fei | |
| 245 | 0 | 0 |
_aCytotherapy with M1-polarized macrophages ameliorates liver fibrosis by modulating immune microenvironment in mice. _h[electronic resource] |
| 260 |
_bJournal of hepatology _c10 2017 |
||
| 300 |
_a770-779 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntigens, Ly _xmetabolism |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 |
_aCarbon Tetrachloride _xtoxicity |
| 650 | 0 | 4 |
_aCell- and Tissue-Based Therapy _xmethods |
| 650 | 0 | 4 |
_aCellular Microenvironment _ximmunology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aHepatic Stellate Cells _xpathology |
| 650 | 0 | 4 |
_aKiller Cells, Natural _ximmunology |
| 650 | 0 | 4 |
_aLiver Cirrhosis _ximmunology |
| 650 | 0 | 4 | _aMacrophage Activation |
| 650 | 0 | 4 |
_aMacrophages _xclassification |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Transgenic |
| 700 | 1 | _aGao, Chun-Chen | |
| 700 | 1 | _aYi, Jing | |
| 700 | 1 | _aZhao, Jun-Long | |
| 700 | 1 | _aLiang, Shi-Qian | |
| 700 | 1 | _aZhao, Yang | |
| 700 | 1 | _aYe, Yu-Chen | |
| 700 | 1 | _aBai, Jian | |
| 700 | 1 | _aZheng, Qi-Jun | |
| 700 | 1 | _aDou, Ke-Feng | |
| 700 | 1 | _aHan, Hua | |
| 700 | 1 | _aQin, Hong-Yan | |
| 773 | 0 |
_tJournal of hepatology _gvol. 67 _gno. 4 _gp. 770-779 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jhep.2017.05.022 _zAvailable from publisher's website |
| 999 |
_c27259928 _d27259928 |
||